Thyroid Eye Disease PBMC
Thyroid Eye Disease PBMC samples are isolated from donors with clinically confirmed Thyroid Eye Disease (TED). Ideal for studying autoimmune responses, T cell and B cell activation, and fibroblast-immune interactions driving orbital inflammation and tissue remodeling in TED.
| Lot # | Condition | Cell Count (M) | Race/Ethnicity | Age | Gender | Country of Collection | Medications | Vials | Price | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| 70181 | Thyroid Eye Disease | 10M | Caucasian | 77 | Male | United States |
Tepezza Methimazole QD M-F Losartan 25mg QD Atorvastatin 20mg QD Sertraline QD Finasteride 1mg QD
|
5 | ||
| 69444 | Thyroid Eye Disease | 10M | Caucasian | 53 | Female | United States |
Synthroid, colanzepin depakote metoprolol vraylar
|
6 | ||
| 69462 | Thyroid Eye Disease | 10M | Caucasian | 55 | Female | United States |
Synthroid QD Zetia QD Protonix QD Allegra D QD Lunesta prn Gabapentin QD Flexeril Nightly
|
4 | ||
| 69341 | Thyroid Eye Disease | 10M | Caucasian | 46 | Female | United States |
Levothyroxine .112, GLP-1, magnesium, Tepezza Synthroid 112 mcg QD Phentermine 37.5 mg QD Celebrex 100 mg PRN Refresh eye drops PRN Systane eye drops PRN
|
8 | ||
| 69370 | Thyroid Eye Disease | 10M | African American | 57 | Female | United States |
Synthroid 88 mcg QD Sertraline 50mg QD Zyrtec OTC QD Amlodipine 10 mg QD
|
3 | ||
| 69369 | Thyroid Eye Disease | 10M | Caucasian | 58 | Female | United States |
Levothyroxine Prescribed eye drops
|
4 |
Thyroid Eye Disease PBMC for Research
Thyroid Eye Disease PBMC samples are collected from donors clinically diagnosed with thyroid eye disease (TED) and processed under controlled conditions to support autoimmune and ophthalmology research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies of T- and B-cell activation and fibroblast–immune interactions driving orbital inflammation and tissue remodeling in TED.
Product Features
- Research Use Only (RUO), cryopreserved thyroid eye disease PBMC samples
- Clinically confirmed thyroid eye disease donors
- Available in cell counts ranging from 5 million to 2 billion
- Processed within 24 hours of collection
- Preserved using CryoStor® CS10 freezing media
- IRB-approved protocols and electronic informed consent
- Screening (LeukoLotâ„¢) available prior to bulk orders
De-identified Donor Data
- Verified thyroid eye disease diagnosis
- Donor demographics: age, sex assigned at birth, race/ethnicity
- Self-reported allergies and infectious disease history
- Additional thyroid eye disease-specific clinical data available on request
Applications
- Biomarker discovery and validation
- Autoimmune and immune-pathway analysis in thyroid eye disease
- Drug screening and therapeutic development
- Transcriptomic and proteomic profiling
Quality and Compliance
- IRB-approved collections and protocols
- 21 CFR Part 11-compliant e-consent
- HIPAA-compliant donor data protection
Ordering & Shipping
Thyroid Eye Disease PBMC samples ship on dry ice in standard or custom aliquots. For international orders or regulatory documentation, contact learnmore@sanguinebio.com. Browse all human PBMCs or request a custom disease-state collection.
Protocols & Documentation
-
Download
PBMC Isolation from Whole Blood
Standard operating procedure for isolating peripheral blood mononuclear cells from whole blood using density-gradient separation.
-
Download
Immune Cell Isolation
Guidelines for isolating immune cell populations with validated enrichment steps, purity checkpoints, and documentation.
-
Download
Choosing the Right PBMC Configuration
Reference guide comparing PBMC formats, cryopreservation states, and study-fit recommendations for your application.
-
Download
Thawing Cryopreserved PBMC
Validated thawing protocol to recover viable cryopreserved PBMCs while minimizing activation and loss of function.
-
Informed Consent Form (ICF)
Available upon request — confirms donor consent for research use and downstream commercialization.
PBMC
Frequently Asked Questions
1 Answer
YES – All collections are conducted under IRB-approved protocols and electronic informed consent. Sanguine utilizes Advarra and WCG IRB for oversight.
1 Answer
YES – all our products are research use only (RUO).
1 Answer
You can find our full product catalog here.
1 Answer
Storage depends on sample type but often cryopreserved samples stored in liquid nitrogen can be stored for years.
1 Answer
Extensive customization is available. To discuss your project request a quote or email us at learnmore@sanguinebio.com.
1 Answer
Sanguine offers flexible prospective collection services tailored to fit your research. For more information and to request a quote, please see: our prospective biospecimen collection services page.
1 Answer
Timelines depend on condition, sample type, and I/E criteria but we often start collection within 2 weeks of signed agreement.
1 Answer
YES – we have in-stock inventory. You can also email us at learnmore@sanguinebio.com as we continually get new samples in our inventory.
1 Answer
Each sample from a different individual – Unique donor means each sample comes from a different person, ensuring biological diversity in your study.
1 Answer
YES – Unique donors can be specified and guaranteed based on your requirements.
1 Answer
For information about sample quality, please see: Quality and Compliance
1 Answer
YES – “IRB-approved collection protocols” and IRB approval documentation available upon request. Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval.
Ask a Question
Need a custom PBMC cohort?
Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.